The JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia
Effects of IL-7 and TLSP on the JAK–STAT signaling pathway and the action of selected inhibitors of pathway components: IL-7 leads to the activation of Janus kinases JAK1 and JAK3, as well as STAT1, STAT3, and STAT5, which are translocated to the cell nucleus, regulating gene expression. TSLP, through heterodimerization of IL-7α with CRLF2, activates JAK1 and JAK2, as well as the effector STAT5, which translocate to the cell nucleus and influences gene expression. Fludarabine is an inhibitor of STAT1, while ruxolitinib and fedratinib are JAK2 inhibitors. By preventing the activation of their target molecules, these drugs exert inhibitory effects on the JAK–STAT pathway
Publication
The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia (2024) Karolina Joanna Ziętara, et al. Int J Mol Sci. 2024 Jul;25(13). Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IL-7Ra | IL-7RA | ncbigene_synonym | IL7R | 3575 |
| Homo sapiens | Primates | IL-7 | IL-7 | ncbigene_synonym | IL7 | 3574 |
| Homo sapiens | Primates | IL-7 | IL-7 | ncbigene_synonym | LINC02605 | 112935892 |
| Homo sapiens | Primates | JAK1 | JAK1 | ncbigene_symbol | JAK1 | 3716 |
| Homo sapiens | Primates | JAK3 | JAK3 | ncbigene_symbol | JAK3 | 3718 |
| Homo sapiens | Primates | STAT1 | STAT1 | ncbigene_symbol | STAT1 | 6772 |
| Homo sapiens | Primates | STAT3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | CRLF2 | CRLF2 | ncbigene_symbol | CRLF2 | 64109 |
| Homo sapiens | Primates | TSLP | TSLP | ncbigene_symbol | TSLP | 85480 |
| Homo sapiens | Primates | JAK2 | JAK2 | ncbigene_symbol | JAK2 | 3717 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| RUXOLITINIB | ruxolitinib | (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile | chebi:66919 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|